An observational post-approval safety study of golimumab in treatment of polyarticular Juvenile Idiopathic Arthritis (pJIA) using the German Biologics JIA Registry (BiKeR)

30/01/2018
09/10/2025
EU PAS number:
EUPAS20781
Study
Ongoing
Documents
Study protocol
Initial protocol
English (518.35 KB - PDF) View document
Updated protocol
English (1.3 MB - PDF) View document
English (1.3 MB - PDF) View document
English (683.14 KB - PDF) View document
Study results
Study report
Other information